Trial Outcomes & Findings for Acute Effect of MMT Peel Powder on Glycemic Response, Satiety, and Food Intake in Adults at Risk for Type 2 Diabetes (NCT NCT05298111)

NCT ID: NCT05298111

Last Updated: 2024-08-15

Results Overview

Blood glucose were measured using glucometer (Accu Chek Performa, New South Wales, Australia) from finger-prick blood samples according to the standard operating procedure at baseline (0 min), 30, 60, 90 and 120 minutes.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

36 participants

Primary outcome timeframe

Baseline (0 min), 30, 60, 90 and 120 minutes on Day 1 and Day 4 of both study visits

Results posted on

2024-08-15

Participant Flow

120 participants were screened for eligibility between 18th August 2021 and 18th October 2021 in Kuala Nerus, Terengganu, Malaysia,

36 of 120 participants were randomized. 84 participants did not meet inclusion criteria.

Participant milestones

Participant milestones
Measure
Formulation 3, Then Control
Participants first consumed 36 g of Formulated MMT peel powder containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast. After a washout period of 3 days, they then consumed 4.5 g glucose containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast.
Control, Then Formulation 3
Participants first consumed 4.5 of glucose containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast. After a washout period of 3 days, they then consumed 36 g formulated MMT peel powder containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast.
First Intervention
STARTED
18
18
First Intervention
COMPLETED
18
18
First Intervention
NOT COMPLETED
0
0
Washout (3 Days)
STARTED
18
18
Washout (3 Days)
COMPLETED
15
15
Washout (3 Days)
NOT COMPLETED
3
3
Second Intervention
STARTED
15
15
Second Intervention
COMPLETED
15
15
Second Intervention
NOT COMPLETED
0
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Formulation 3, Then Control
Participants first consumed 36 g of Formulated MMT peel powder containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast. After a washout period of 3 days, they then consumed 4.5 g glucose containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast.
Control, Then Formulation 3
Participants first consumed 4.5 of glucose containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast. After a washout period of 3 days, they then consumed 36 g formulated MMT peel powder containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast.
Washout (3 Days)
Withdrawal by Subject
3
3

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Formulation 3 Then Control
n=15 Participants
Formulated MMT peel powder (provide 5 g dietary fiber per day) Respondents were consumed 36 g of Formulation 3 then 4.5 g of control, both containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast.
Control Then Formulation 3
n=15 Participants
Glucose Control: Respondents were consumed 4.5 g of control then 36 g of Formulation 3, both containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Total
n=30 Participants
Total of all reporting groups
Age, Continuous
35.7 years
STANDARD_DEVIATION 4.5 • n=15 Participants
37.9 years
STANDARD_DEVIATION 6.8 • n=15 Participants
36.1 years
STANDARD_DEVIATION 8.7 • n=30 Participants
Sex: Female, Male
Female
11 Participants
n=15 Participants
12 Participants
n=15 Participants
23 Participants
n=30 Participants
Sex: Female, Male
Male
4 Participants
n=15 Participants
3 Participants
n=15 Participants
7 Participants
n=30 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
Malaysia
15 Participants
n=15 Participants
15 Participants
n=15 Participants
30 Participants
n=30 Participants

PRIMARY outcome

Timeframe: Baseline (0 min), 30, 60, 90 and 120 minutes on Day 1 and Day 4 of both study visits

Blood glucose were measured using glucometer (Accu Chek Performa, New South Wales, Australia) from finger-prick blood samples according to the standard operating procedure at baseline (0 min), 30, 60, 90 and 120 minutes.

Outcome measures

Outcome measures
Measure
Formulation 3
n=30 Participants
Respondents were consumed 36 g of Formulation 3 containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Control
n=30 Participants
Respondents were consumed 4.5 g of control containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Blood Glucose Levels
60 min
7.4 mmol/L
Standard Deviation 1.0
8.2 mmol/L
Standard Deviation 1.2
Blood Glucose Levels
0 min
5.6 mmol/L
Standard Deviation 0.4
5.7 mmol/L
Standard Deviation 0.4
Blood Glucose Levels
30 min
6.7 mmol/L
Standard Deviation 0.6
7.7 mmol/L
Standard Deviation 0.7
Blood Glucose Levels
90 min
6.9 mmol/L
Standard Deviation 0.8
7.0 mmol/L
Standard Deviation 1.0
Blood Glucose Levels
120 min
6.5 mmol/L
Standard Deviation 0.6
6.1 mmol/L
Standard Deviation 0.6

SECONDARY outcome

Timeframe: Day 1 and 4 of both study visits

Perceived satiety measurements were rated using a 10-cm visual analogue scale (VAS) which consisted of hunger (How hungry are you?), fullness (How full are you?), desire to eat (How strong is your desire to eat?), prospective food consumption (How much would you be able to eat right now?) and thirstiness (How thirsty are you?) (Tey, Salleh, Henry, \& Forde, 2017). The scale ranged from 0 (not at all) to 10 (very much) measured at baseline (0 min), 30, 60, 90 and 120 minutes. The area under the curve was calculated using trapezoid rule.

Outcome measures

Outcome measures
Measure
Formulation 3
n=30 Participants
Respondents were consumed 36 g of Formulation 3 containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Control
n=30 Participants
Respondents were consumed 4.5 g of control containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Perceived Satiety (Area Under the Curve)
Hunger
200.5 score on a scale*min
Standard Error 22.3
277 score on a scale*min
Standard Error 32.4
Perceived Satiety (Area Under the Curve)
Fullness
912 score on a scale*min
Standard Error 34
822.5 score on a scale*min
Standard Error 41.6
Perceived Satiety (Area Under the Curve)
Desire to eat
231 score on a scale*min
Standard Error 21.9
329 score on a scale*min
Standard Error 32.4
Perceived Satiety (Area Under the Curve)
Prospective food consumption
263 score on a scale*min
Standard Error 31
344.5 score on a scale*min
Standard Error 35
Perceived Satiety (Area Under the Curve)
Thirstiness
486.5 score on a scale*min
Standard Error 51.5
499.5 score on a scale*min
Standard Error 45.1

SECONDARY outcome

Timeframe: Day 1 and 4 of both study visits

The respondents were asked to record all the food or drink they had consumed including sauces, soup and gravies using household measures once they woke up in the morning until they went to sleep at night.

Outcome measures

Outcome measures
Measure
Formulation 3
n=30 Participants
Respondents were consumed 36 g of Formulation 3 containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Control
n=30 Participants
Respondents were consumed 4.5 g of control containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Food Intake
Carbohydrate
219.3 g
Interval 163.3 to 334.5
225.2 g
Interval 143.2 to 371.6
Food Intake
Protein
74.1 g
Interval 52.2 to 106.4
75.3 g
Interval 55.0 to 112.3
Food Intake
Fat
74.3 g
Interval 46.7 to 108.9
77.2 g
Interval 50.3 to 118.5
Food Intake
Dietary fiber
10.9 g
Interval 8.2 to 13.9
6.1 g
Interval 2.7 to 10.4

SECONDARY outcome

Timeframe: Day 1 and day 4 of both study visits

The respondents were asked to record all the food or drink they had consumed including sauces, soup and gravies using household measures once they woke up in the morning until they went to sleep at night.

Outcome measures

Outcome measures
Measure
Formulation 3
n=30 Participants
Respondents were consumed 36 g of Formulation 3 containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Control
n=30 Participants
Respondents were consumed 4.5 g of control containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Calories Intake
1796 kcal
Interval 1424.0 to 2569.0
1893 kcal
Interval 1434.0 to 2476.0

OTHER_PRE_SPECIFIED outcome

Timeframe: Day 1 and 4 of both study visits

Body weight was taken at every study visit.

Outcome measures

Outcome measures
Measure
Formulation 3
n=30 Participants
Respondents were consumed 36 g of Formulation 3 containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Control
n=30 Participants
Respondents were consumed 4.5 g of control containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Body Weight (kg)
75.1 kg
Standard Deviation 14.9
75.1 kg
Standard Deviation 15.0

OTHER_PRE_SPECIFIED outcome

Timeframe: Day 1 and 4 of both study visits

Height was taken at every study visit.

Outcome measures

Outcome measures
Measure
Formulation 3
n=30 Participants
Respondents were consumed 36 g of Formulation 3 containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Control
n=30 Participants
Respondents were consumed 4.5 g of control containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Height (cm)
158.6 cm
Standard Deviation 6.3
158.6 cm
Standard Deviation 6.4

OTHER_PRE_SPECIFIED outcome

Timeframe: Day 1 and 4 of both study visits

BMI was calculated using formula = body weight (kg)/height (m)\^2

Outcome measures

Outcome measures
Measure
Formulation 3
n=30 Participants
Respondents were consumed 36 g of Formulation 3 containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Control
n=30 Participants
Respondents were consumed 4.5 g of control containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Body Mass Index (BMI) (kg/m^2)
29.8 kg/m^2
Standard Deviation 5.1
29.8 kg/m^2
Standard Deviation 5.1

OTHER_PRE_SPECIFIED outcome

Timeframe: Day 1 and 4 of both study visits

% body fat was taken at every study visit.

Outcome measures

Outcome measures
Measure
Formulation 3
n=30 Participants
Respondents were consumed 36 g of Formulation 3 containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Control
n=30 Participants
Respondents were consumed 4.5 g of control containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
% Body Fat
38.9 Percentage
Standard Deviation 8.1
39.0 Percentage
Standard Deviation 8.3

OTHER_PRE_SPECIFIED outcome

Timeframe: Day 1 and 4 of both study visits

Waist circumference was taken at every study visit.

Outcome measures

Outcome measures
Measure
Formulation 3
n=30 Participants
Respondents were consumed 36 g of Formulation 3 containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Control
n=30 Participants
Respondents were consumed 4.5 g of control containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Waist Circumference (cm)
91.2 cm
Standard Deviation 11.0
91.0 cm
Standard Deviation 11.3

OTHER_PRE_SPECIFIED outcome

Timeframe: Day 1 and 4 of both study visits

Blood pressure was measured using an Omron automatic digital blood pressure monitor (Omron HEM-7221) in a seated position at all visits after 5 min of sitting.

Outcome measures

Outcome measures
Measure
Formulation 3
n=30 Participants
Respondents were consumed 36 g of Formulation 3 containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Control
n=30 Participants
Respondents were consumed 4.5 g of control containing 4.5 g of available carbohydrate dissolved in 180 ml water with study breakfast
Blood Pressure
systolic blood pressure
124 mmHg
Standard Deviation 14
122 mmHg
Standard Deviation 15
Blood Pressure
diastolic blood pressure
77 mmHg
Standard Deviation 9
75 mmHg
Standard Deviation 9

Adverse Events

Formulation 3

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Ms Ong Ying Qian

Universiti Sultan Zainal Abidin

Phone: +60142186195

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place